Search

Your search keyword '"He, Licai"' showing total 40 results
Start Over Author "He, Licai" Database Unpaywall
40 results on '"He, Licai"'

2. Figure S5 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

3. Table S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

4. Table S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

5. Figure S3 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

6. Data from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

7. Figure S4 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

8. Figure S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

9. Figure S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

10. Data from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

11. Table S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

12. Figure S5 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

13. Table S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

14. Figure S4 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

15. Figure S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

16. Figure S3 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

17. Figure S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

24. A novel humanized MUC1 antibody–drug conjugate for the treatment of trastuzumab-resistant breast cancer

Author

Wu, Guang, primary, Li, Lan, additional, Qiu, Yuxin, additional, Sun, Wei, additional, Ren, Tianhao, additional, Lv, Yingshuai, additional, Liu, Mengnan, additional, Wang, Xiaoxia, additional, Tao, Hongqun, additional, Zhao, Lingjie, additional, Cao, Jiawei, additional, He, Licai, additional, Li, Hongzhi, additional, and Gu, Haihua, additional

Published
2021
Full Text
View/download PDF

25. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α

Author

Cao, Jiawei, primary, Wu, Du, additional, Wu, Guang, additional, Wang, Yaqi, additional, Ren, Tianhao, additional, Wang, Yang, additional, Lv, Yingshuai, additional, Sun, Wei, additional, Wang, Jieyi, additional, Qian, Changrui, additional, He, Licai, additional, Yang, Kaiyan, additional, Li, Hongzhi, additional, and Gu, Haihua, additional

Published
2021
Full Text
View/download PDF

33. Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, additional, Song, Hao, additional, Chen, Yuanzhi, additional, Xie, Jingjing, additional, Li, Zunling, additional, He, Licai, additional, Huang, Fangfang, additional, Xu, Yixiang, additional, Anami, Yasuaki, additional, Yu, Hai, additional, Yu, Chenyi, additional, Li, Leike, additional, Yuan, Zihao, additional, Xu, Xiaoying, additional, Wang, Qihui, additional, Chai, Yan, additional, Huang, Tao, additional, Shi, Yi, additional, Tsuchikama, Kyoji, additional, Liao, X. Charlene, additional, Xia, Ningshao, additional, Gao, George F., additional, Zhang, Ningyan, additional, Zhang, Cheng Cheng, additional, and An, Zhiqiang, additional

Published
2019
Full Text
View/download PDF

34. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

Author

Deng, Mi, primary, Gui, Xun, additional, Kim, Jaehyup, additional, Xie, Li, additional, Chen, Weina, additional, Li, Zunling, additional, He, Licai, additional, Chen, Yuanzhi, additional, Chen, Heyu, additional, Luo, Weiguang, additional, Lu, Zhigang, additional, Xie, Jingjing, additional, Churchill, Hywyn, additional, Xu, Yixiang, additional, Zhou, Zhan, additional, Wu, Guojin, additional, Yu, Chenyi, additional, John, Samuel, additional, Hirayasu, Kouyuki, additional, Nguyen, Nam, additional, Liu, Xiaoye, additional, Huang, Fangfang, additional, Li, Leike, additional, Deng, Hui, additional, Tang, Haidong, additional, Sadek, Ali H., additional, Zhang, Lingbo, additional, Huang, Tao, additional, Zou, Yizhou, additional, Chen, Benjamin, additional, Zhu, Hong, additional, Arase, Hisashi, additional, Xia, Ningshao, additional, Jiang, Youxing, additional, Collins, Robert, additional, You, M. James, additional, Homsi, Jade, additional, Unni, Nisha, additional, Lewis, Cheryl, additional, Chen, Guo-Qiang, additional, Fu, Yang-Xin, additional, Liao, X. Charlene, additional, An, Zhiqiang, additional, Zheng, Junke, additional, Zhang, Ningyan, additional, and Zhang, Cheng Cheng, additional

Published
2018
Full Text
View/download PDF

37. Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Author

He, Licai, primary, Du, Zhuanyun, additional, Xiong, Xusheng, additional, Ma, Hua, additional, Zhu, Zhenfeng, additional, Gao, Hongwei, additional, Cao, Jiawei, additional, Li, Tong, additional, Li, Hongzhi, additional, Yang, Kaiyan, additional, Chen, Guorong, additional, Richer, Jennifer K., additional, and Gu, Haihua, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results